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Double Immunofluorescence Microscopy: A Method for Localizing 
Immune Deposits in Skin Diseases Associated with Linear Basement 
Membrane Zone Immunofluorescence 
W. RAY GAMMON, M.D., TED ROBINSON, ROBERT A. BRIGGAMAN, M.D., AND CLAYTON E. WHEELER, JR., M.D. 
Department of Dermatology, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, U.S.A. 
Direct immunofluorescence microscopy has shown 
that a linear pattern of immunoglobulin and/or comple-
ment deposition at the cutaneous basement membrane 
zone is a characteristic feature in a number of acquired 
bullous diseases and is occasionally observed in systemic 
lupus erythematosus. Immunoelectron microscopy has 
shown the linear pattern of immunofluorescence may be 
produced by immune deposits located either above the 
basal lamina (in the lamina lucida) or below the basal 
lamina (in the upper dermis). Distinguishing between 
these sites of in;unune reactant deposition may be of 
value in differential diagnosis. In this study we report a 
double immunofluorescent method by which skin biop-
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Abbreviations: 
BMZ: basement membrane zone 
BP: bullous pemphigoid 
CP.: cicatricial pemphigoid 
EBA: epidermolysis bullosa acquisita 
FITC: fluorescent isothiocy.anate-conjugated 
HG: herpes gestation is 
NHS: normal human serum 
PBS: phosphate-buffered saline 
RITe: rhodamine isothiocyanate-conjugated 
SLE: systemic lupus erythematosus 
sies with linear IgG immunofluorescence due to deposits 
above the basal lamina (bullous pemphigoid) could be 
distinguished from biopsies with deposits beneath the 
basal lamina (bullous systemic lupus erythematosus and 
epidermolysis bullosa acquisita). When skin sections 
were treated sequentially with rhodamine-labeled anti-
human IgG followed by fluorescein-labeled antilamina 
lucida (pemphigoid) antibody and examined by fluores-
cence microscopy, the following results were obtained. 
In biopsies with IgG deposits in the lamina lucida, a 
single green fluorescent band was observed. In tissues 
with subbasal lamina deposits, either parallel and con-
tiguous bands of green and yellow-orange fluorescence 
or a single band of yellow-orange fluorescence was ob-
served. The method is simpler, quicker, and less expen-
sive than immunoelectron microscopy and should be a 
useful technique for evaluating skin diseases with linear 
immunofluorescence at the basement membrane zone. 
Standard direct immunofluorescence microscopy using fluo-
rochrome-labeled antibodies to human immunoglobulins (Ig) 
and complement (C) components has been of value in the 
differential diagnosis of skin diseases, particularly the acquired 
bullous diseases [1]. However, the value of the technique has 
been limited due to difficulties in distinguishing between dis-
eases associated with similar clinical and histologic features and 
an identical location, pattern, and composition of immune reac-
tant deposition in skin. 
Limitations in differential diagnosis by direct immunofluo-
rescence are commonly encountered in diseases associated with 
a linear pattern of IgG and/or C3 deposition at the cutaneous 
basement membrane zone (BMZ) . This pattern is characteristic 
of bullous pemphigoid (BP), cicatricial pemphigoid (CP), and 
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herpes gestationis (HG) but is also observed in most patients 
with epidermolysis bullosa acquisita (EBA) [2-6). Although 
uncommon, the homogeneous band of fluorescence seen in 
systemic lupus erythematosus (SLE) may appear linear [7-10). 
In recent years immunoelectron microscopic studies have 
shown that the immune reactants in BP, CP, and HG are 
deposited above the basal lamina in the lamina lucida [11-14). 
Similar studies have shown the deposits in SLE and EBA are 
in the upper dermis just beneath the basal lamina [4-6,15,16). 
At the present time only inlmunoeJectron microscopy can reli-
ably determine the precise location of immune reactants in 
diseases with a linear pattern of in1munofluoi'escence at the 
BMZ. 
Since ultrastructural studies are technically more difficult, 
require more expensive equipment, are more time consuming, 
and less available than inmlUnofluorescence, we have developed 
an immunofluorescence method that allows a relatively rapid 
and simple means of discriminating among diseases with linear 
IgG BMZ immunofluorescence due to suprabasal and subbasal 
immune reactants. In the method, tissue containing linear BMZ 
deposits of IgG in the lamina lucida (BP) or beneath the basal 
lamina (EBA, bullous SLE) were treated sequentially with 
J'hodamine isothiocyanate (RITC)-conjugated antihuman IgG 
and fluorescein isothiocyanate (FITC)-conjugated antibody to 
the lamina lucida (BP antibody). Tissues were then examined 
by fluorescence microscopy using fluorescein and fluorescein-
}'hodamine barrier filters. In tissues with IgG deposits in the 
lamina lucida a single green fluorescent band was detected. In 
tissues with subbasal lamina deposits, either parallel linear 
bands of green and yellow-orange fluorescence or a single band 
of yellow-orange fluorescence was observed. 
MATERIALS AND METHODS 
Rea.gents 
Horseradish peroxidase, fluorescein isothiocyanate, and 3,3' -diami-
nobenzidine tetrahydrochloride were purchased from Sigma Chemical 
Co., St Louis, Missouri . Osmium tetroxide was purchased from Poly-
sciences, Warrington, Pennsylvania. The following monospecific anti-
sera were purchased from Cappel Labs, Cocluanville Pennsylvania: 
RITC-conjugated goat antihuman IgG; FITC-conjugated goat antisera 
to human IgG , IgA, IgM , and C3; FITC-conjugated rabbit antigoat IgG 
a nd goat anti horseradish peroxidase. Buffers included: 0.15 M NaCI 
buffered with 0.01 M Na2HPO" and 0.01 M NaH2PO" pH 7.2 (PBS); 
0.05 M Tris buffer, pH 7.6, and 0.1 M PO, buffer, pH 7.4. Horseradish 
peroxidase solution was prepm'ed by dissolving 1.0 mg horseradish 
peroxidase in 20.0 ml PBS. Graham-Karnowsky solution was prepared 
by dissolving 5.0 mg 3,3'-diaminobenzidine tetra hydrochloride in 25.0 
ml Tris buffer and adding 1 drop of H 20 2 [17]. One percent osmium 
tetroxide was prepm'ed in 0.1 M PO, buffer. 
Sera 
Normal human serum (NHS) was obtained from a single donor, 
heat-inactivated at 56°C for 30 min and stored in 1.0 ml aliquots at 
-20°C. Serum from a patient with BP with an IgG anti-BMZ antibody 
titer of 1:320 was used as a source of antibody to the lamina lucida 
(anti-lamina lucida antibody). 
Shin 
Three- to four-mm punch biopsies of perilesional skin were obtained 
from each of 4 patients with BP, 4 patients with EBA, and 2 patients 
with bullous SLE. All patients were diagnosed by established clinical, 
histologic, immunohistologic, and serologic criteria [6,18,19). Fresh-
frozen human foreskin was obtained following routine circumcision of 
healthy neonates and quick-frozen in liquid N 2 • Two 3-mm biopsies of 
normal human adult skin were obtained from volunteers and placed in 
"transport media" for 7 days at 25°C and then quick-frozen in liquid N2 
[20). Following quick-fl'eezing, all tissues were mounted in OCT com-
pound (Ames Co, Elkhart, Indiana) and stored at -70°C. 
FITC,Conjuga.ted An.ti·Lamina Lucida Antibody 
A crude Ig fraction of BP serum was prepm'ed as follows: 10.0 Inl 
serum was diluted with an equal volume of cold distilled H 20 and 
slowly mixed with 20.0 ml of a saturated solution of ammonium sulfate 
(SAS) at 4°C. The mixture was stored overnight at 4°C arid the 
precipitate recovered, washed twice with 25% SAS, redissolved in 0.15 
M NaCI a nd dialyzed 24 hr against 0.85 M NaCI at 4°C. The protein 
concentration (OD280) of the diaJysate was adjusted to 10.0 mg/ m1. 
and 10.0 ml was mixed with an equal volume of 0.5% FITC dissolved in 
0.75 M NaH,C03-O.15 M NaCI, pH 9.0. The mLxture was stored at 2qOC 
for 4 hl' and dialyzed against 0.85 M NaCI for 24 hI' at 4°C. A portion of 
the FITC-conjugated Ig fraction was absorbed with 25% (vol:vol) guinea 
pig liver powder for 1 hI' at 25°C. Final protein concentration and molar 
F /P ratio of the undiluted material was 5.0 mg/ ml and 0.33, respectively 
[21]. This material diluted 1:4-1:20 in PBS produced a fine lin em' band 
of green fluorescence at the BMZ when incubated with cryostat sections 
of normal human or transport-media-treated skin. 
Immunofluorescent Technique 
Standard direct immunofluorescence was performed on all skin biop-
sies according to the method of Beutner and Nisengm'd using mono-
specific FITC-conjugated goat an t isera against human IgG, IgA, IgM, 
and C3 and RITC-conjugated goat antihuman IgG [22). All FITC-
conjugated antisera were used at a dilution of 1:10 in PBS. Specific 
antibody or protein concentrations and molm' fluorescein/ protein ratios 
on undiluted FITC-conjugated antisera were: 6.1 mg/ ml and 3.2 for 
anti·IgG; 3.0 mg/ ml and 3.0 for anti-IgA, 1.9 mg/ ml and 3.3 for anti-
IgM, and 30.0 mg/ ml and 2.0 for anti-C3. RITC-conjugated antihuman 
IgG was used at a dilution of 1:20 in PBS. Protein and rhodomine/ 
protein ratio on the undiluted material was 15 mg/ ml and 3.0, respec-
tively. Tissues were examined for fluorescence at 300X and 500x 
magnification. 
Double immunofluorescence was performed <!s follows: 6-/IDl thick 
cryostat sections of skin were cut and air dried on glass slides. Section 
were then incubated for 30 min in a humidity chamber at 25°C with a 
1:20 dilution of RITC-conjugated goat an tihuman IgG. Sections then 
received a stmldm'd 15-min rinse in 3 changes of PBS, excess moistUJ'e 
was removed, and sections incubated 15 min at 25°C with 50% heat-
inactivated (56°C X 30 min) NHS diluted in PBS. Following a second 
15-min rinse, sections were incubated with 50 j.il of a 1:4 dilution of 
FITC-conjugated anti-lamina lucida antibody, rinsed for 15 min, and 
coverslipped. Immunofluorescence was interpreted independently by 2 
investigators without knowledge of the disease being examined. All 
immunofluorescence was read at 300x and 500X using a Leitz Orthoplan 
fluorescence microscope equipped with epi-illumination and appropri-
ate filters. Leitz filter systems used included: (1) for fluorescein fluQl'es-
cence, excitol' filter BP 450-490, barrier filter LP 515, and beanl splitter 
P KP 510; (2) for rhodomine, exicter filter BP 530-560, bmTier filter LP 
580, and beam splitter P KP 580; (3) for combination rhodamine and 
fluorescein fluorescence, excitor ftlter BP 450-500, barrier filter LP 515-
560, and beam splitter l' KP 510. 
RESULTS 
Standard Direct Immunofluorescence of Biopsies trom 
Patients with BP, EBA, and Bullous SLE 
The results of direct immunofluorescence on 10 patients with 
EBA, BP, and bullous SLE are shown in Table I. There was a 
linear pattern of IgG staining in all biopsies. C3 was present in 
all 4 biopsies from patients with BP, the 2 patients with bullous 
SLE, and in 2/4 biopsies of EBA. In addition, trace deposits of 
IgA and IgM were present in several biopsies from patients 
with SLE and BP. By direct inlmunofluorescence all biopsies 
showed a homogeneous linear band of IgG at the BMZ. By 
standard direct immunofluorescence alone, it was not possible 
to reliably discriminate among biopsies from patients with BP, 
EBA, and bullous SLE. 
Immunoelectron Microscopy 
All biopsies from patients with SLE, EBA, and BP were 
examined by immunoeJectron microscopy using a previously 
described method [6). Results are shown in Table I and Figs 1-
3. Immune deposits were observed in the lamina lucida in all 4 
biopsies from patients with BP. Deposits were present in the 
upper dermis just beneath the basal lamina in the 6 biopsies 
from patients with SLE and EBA. In these 6 tissues, peroxidase-
labeled deposits formed a relatively homogeneous band that 
was approximately 2-3 times the width of the deposits seen in 
BP (Fig 1). In the 2 biopsies from SLE skin there were, in 
addition to sub-basal lamina deposits, less conspicuous globular 
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TABLE I. Results of standard direct immunofluorescence, immunoeLecLron microscopy, and dou.bLe immunofluorescence in biopsies of SLE, 
























S landard direc l immunoOuorescence 
Paltern Composition 
Linear BMZ IgG, C3 
Lineru' BMZ IgG, C3, IgA 
LinearBMZ IgG, C3, IgA 
Linear BMZ IgG, C3 
Lineru' BMZ IgG 
Linear BMZ IgG 
Linear BMZ IgG, C3 
LinearBMZ IgG, C3 
LinearBMZ IgG, C3, IgM 
Linear BMZ IgG, C3, IgA 
Immunoelectron microscopy 
Double immunoOuorescence 
Location of immune reactant 
Lamina lucida Linear green band 
Lamina lucida Lineru' green band 
Lamina lucida Lineru' green band 
Lamina lucida Linear green band 
Subbasal lamina Green and yellow-orange band 
Subbasal lamina Yellow-orange band 
Subbasal lamina Green and yellow-orange band 
Subbasal lamina Green and yellow-orange band 
Subbasal lamina Green and yellow-orange band 
Subbasal lamina Green and yellow-orange band 
FIC 1. Immunoelectron micrograph of' biopsy # 1 from a patient with bullous pemphigoid. IgG immune deposits (D) are located in the lamina 
lucida above the basal lamina (B). An identical location of IgG deposits were observed in biopsies #1-4. Magnification 5.8 x 10". 
deposits distributed randomly In the upper dermis and fine 
deposits in vessel walls. 
Double Immunofluorescence 
Both observers interpreted the results of double immunofluo-
rescence independently and agreed on the findings which are 
shown in Table II. As the table indicates, there were 3 patterns 
of immunofluorescence in the 10 tissues and the same 3 patterns 
were observed with both the fluorescein and fluorescein-rho-
damine fIl ters. The patterns observed were: (1) a linear green 
fluorescence in 4 tissues, (2) a linear band composed of contig-
uous and parallel green and yellow-orange bands in 5 tissues, 
and (3) a single yellow-orange band in 1 tissue. Using the 
rhodamine filter, the 6 tisssues (patterns 2 and 3) with yellow-
orange fluorescence showed only a single red band. In the 5 
t issues showing parallel green and yellow-orange fluorescence, 
th e parallel bands seemed to merge in some areas along the 
BMZ into a single yellow-orange band. A comparison of the 
source of tissue with the results of double fluorescence (Table 
I) showed that the green band pattern was seen only in tissue 
from patients with BP. The parallel green and yellow-orange 
band was seen in the 2 patients with SLE and 3 patients with 
EBA. The single yellow-orange band was seen in a patient with 
EBA. In all cases, fluorescence was as easily observed and 
interpreted with the fluorescein filter alone as with the combi-
nation fluorescein-rhodamine filter. 
DISCUSSION 
It is widely appreciated that direct immunofluorescence mi-
croscopy is a useful if not essential tool in the complete evalu-
ation of skin diseases associated with cutaneous deposits of Ig 
and C. Its value in the differential diagnosis of acquired bullous 
and collagen vascular djseases has been particularly well estab-
lished and the increasing availability of the test has added 
considerably to its value in the work-up and management of 
these illnesses. Direct immunofluorescence is now available in 
virtually all medical centers, many community hospitals, and, 
with the development of transport media, has become accessible 
to all physicians. 
In spite of its value, standard direct immunofluorescence does 
have limitations as a diagnostic procedure. One of its major 
limitations is the ina bility to reliably distinguish among diseases 
associated with a similar pattern and composition of immune 
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FIG 2. Immunoelectron micrograph of biopsy #9 from a patient with systemic lupus erythematosus. IgG deposits (D) are concentrated below 
the basal lamina (B). The lamina lucid a (L) is re latively free of deposits. An identical location of IgG deposits wa observed in biopsies #9 and 
#10. Magnification 6.5 x 10". 
FIG 3. lmmunoelectron micrographs of biopsy #5 from a pat ient with epidermolysis buUosa acq uisita. IgG deposits (D) w·e beneath the basal 
Lamina (B). The lamina lucida (L) is free of deposits. An identical location oflgG deposits was observed in biopsies #5-8. Magnification 4.2 X 10'. 
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TABLE II. Pattern of doub le immunofluorescence in ten biopsies 
{rom patients with BP, EBA, and bullous SLE 
Pallerns 
BX # Fluorescein-rhodamine Rhodamine Fluorescein filler fil ler filter 
4 Linea.r green Linear green 
5 Linear green, yellow- Linear green, yellow- Linear red 
orange orange 
1 Lineal' ye llow-orange Linear ye llow-orange Linear red 
reactant deposition in skin . For example, BP, CP, HG, and 
EBA characteristically have a linear pattern of IgG and/or C3 
deposition. Uncommonly, SLE may show a similar pattern and 
composition of reactants. In most cases, discrimination among 
these illnesses can be made on clinical or serologic and perhaps 
less commonly on histologic features alone; however, many 
cases lack distinctive serologic and histologic features and clin-
ical and histologic overlaps occasionally occw·. Of course, direct 
immunofluorescence in SLE is usually distinctively thready, 
stippled, or granular. Therefore, it is only in those very uncom-
mon cases with a "linear-appearing" band that double immu-
nofluorescence might be useful. 
Immunoelectron microscopy has shown that among diseases 
with linear BMZ, IgG, or C3 immunofluorescence there are at 
least 2 distinctive ultrastructural sites of immune reactant 
deposition, above and below the basal lamina. BP, CP, and HG 
have deposits above the basal lamina in t he lamina lucida. In 
EBA and SLE, the deposits are in the upper dermis beneath 
the basal lamina [2, 3]. 
Distinctions among diseases with linear IgG deposits in a 
suprabasal or subbasal lamina location al'e difficult if not im-
possible by standal'd direct immunofluorescence, Although it 
has been stated that immune deposits in EBA and SLE produce 
a wider fluorescent band than th ose in BP, CP, and HG, we 
and others have experienced difficulties in appreciating this 
difference particularly in EBA and have had to resort to im-
munoelectron microscopy to confirm their location [6]. Fur-
thermore, we know of no studies t hat have documented a 
difference in wid th between the fluorescent bands in these 
diseases, From our experience, it appears that band width is 
variable and often a function of the plane of sectioning of the 
tissue, In any event, conclusions about t he ultrastructural lo-
cation of immune reactants based on a subjective impression of 
band width are not likely to be reliable. 
There are several features of the double immunofluorescence 
technique that merit discussion. First, the method required 
incubation of skin sections with normal human serum following 
the initial incubation with RITC-conjugated antihuman IgG, 
This step was included to saturate th e RITC-conjugated anti-
human IgG binding sites not occupied by in vivo deposited IgG, 
It was assumed that had this step been omitted t he RITC-
conjugated antihuman IgG might bind the FITC-labeled anti-
lamina lucida antibody and either block rhodamine fluorescence 
01' i?terfere with binding of th e FITC-labeled reagent to the 
lamIna lUCIda, Indeed, when incubatIOn with human serum was 
omitted (results not shown) t he tissues that showed a double 
fluorescent band with the standard procedure (EBA and SLE) 
showed only a single band of green fluorescence, 
Ano~heJ: con~id~ration was the availability of BP antigen in 
BP skm tor bIndIng to the FITC-Iabeled anti- lamina lucida 
antibody. It is possible that saturation of BP antigen in vivo by 
anti-BMZ antibodies could block binding of th e FITC-conju-
gated reagent in vitro, Under these circumstances, no green 
fluorescence would be expected and the tissue would presum-
ably show only the yellow-orange fluorescence of rhodamine. 
T his was not the case in. any of our t issues; however, the 
possibility that it might occur cannot be excluded. 
Since it can be assumed that RITC-conjugated antihuman 
IgG as well as FITC-conjugated anti-lamina lucida antibody 
bound to BP skin, a question arises as to why only green 
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fluorescence was observed. We can only assume that in those 
cases where both reagents bind to the same ultrastructuJ'al 
location, the green fluorescence of the FITC conjugate is vis-
ually dominant. This assumption is reinforced by t he observa-
tion that when NHS was omitted from the procedure, only 
green fluorescence was observed in all t issue even though both 
fluorescent reagents were apparently bound in skin. 
The precise ultrastructUJ'allocalization of immune reactants 
in patients with linear IgG BMZ immunofluorescence is of more 
than academic interest, For example, patients with EBA and 
bullous SLE may present with bullous lesions clinically and 
histologically similar to those seen in BP [6,10,23). 
In our experience, patients with bullous SLE may present 
with a clinical pictUJ'e similar to BP and histologic and direct 
immunofluorescent findings of acute dermal inflammation with 
subepidermal blister formation and linear BMZ immunofluo-
rescence [23]. We have recently encountered 2 such patients 
and others have been described in the literatUJ'e [10]. Of partic-
ular interest are a numbel' of case reports of coexistent BP and 
SLE [24-27]. In none of these was the precise location of 
immune reactants identified. In most of these cases coexistence 
of the 2 diseases was based entirely on the clinical and serologic 
findin gs of SLE, bullous skin lesions, and linear BMZ immu-
nofluorescence, These criteria alone are insufficient for the 
diagnosis of both diseases unless it is known whether immune 
reactants are deposited above or below the lamina densa. 
In this study we have described a procedUJ'e for localizing 
IgG immune reactants above or below the basal lamina. The 
method is technically easier , less t ime consuming, a nd less 
expensive than immunoelectron microscopy. It, of course, does 
not replace the more refined ultl'astructural technique, nor is it 
likely to be as accurate; however, it should be of value to those 
who lack facilities for electron microscopy as a rapid prelimi-
nary test for discriminating among diseases with immune de-
posits above and below the basal lamina. Although we have 
examined only diseases with IgG deposits in this study, the 
same method should be applicable to diseases with IgA deposits. 
The findings that the FITC-conjugated anti-lamina lucida an-
tibody binds to the BMZ of tissues stored in transport media 
suggest these tissues could also be processed for double immu-
nofluorescence. 
The authors would like to express their sincere appreciation to Mrs. 
Virgin ia S. Moore for her superb preparation of this manuscript. 
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The distribution of peripheral blood T cells bearing Fc 
receptors for IgG (Ty) and IgM (TJ.I) was determined in 
18 patients with cutaneous T-cell lymphoma (Sezary 
syndrome, mycosis fungoides) and 15 normal controls. 
The mean percent of TJ.I and Ty cells in the patients with 
morphologically normal lymphocytes was similar to that 
of the control subjects. In 13 patients with circulating 
malignant cells representing 30-100% of their peripheral 
blood lymphocytes, the mean percentages of TJ.I and Ty 
were low. In 9 patients the majority of the malignant T 
cells did not exhibit Fc receptors for IgG or IgM. In some 
patients, however, high blood lymphocyte counts re-
sulted in normal or high concentrations of all the T-cell 
subsets. Further, in 4 patients, lymphocytes with the 
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AET: 2-aminoethylisothiow-onium bromide 
CT CL: cutaneous T-cell lymphoma 
OXEA: ox red cell-w1t ibody 
PWM : pokeweed mi togen 
SRBC: sheep red blood cells 
characteristic nuclear abnormalities of "Sezary /my-
cosis" cells were found in both the TJ.I and Ty, as well as 
the TnonynonJ.l, subpopulations. The heterogeneity of the 
Fc receptors on cutaneous T-cell lymphoma lymphocytes 
suggests that these receptors are not useful as clonal 
markers in these disorders. 
The term cutaneous T-cell lymphoma (CTCL) describes a 
spectrum of malignant Iymphoproliferative disorders primarily 
involving the skin that includes mycosis fungoides and the 
Sezary syndrome [I). The Sezary syndrome is characterized by 
an exfoliative erythroderma, generalized lymphadenopathy, 
and circulating abnormal lymphocytes. Approximately 20-40% 
of patients with mycosis fungoides also have peripheral blood 
involvement demonstrable by light and electron microscopy [2-
4). The abnormal cell (the CTCL or "Seuuy/mycosis" cell) is 
a lymphocyte of variable size with a high nuclear to cytoplasmic 
ratio, characteristic convoluted or cerebriform nuclear contours, 
and often dense nuclear chromatin. These cells usually display 
properties of T cells in that they form rosettes with sheep red 
blood cells (SRBC) , react with anti-T-cell antisera, and are 
found in the paracortical areas of involved lymph nodes [5-7]. 
Recently, subpopulations of T cells have been described 
which possess receptors for the Fc portion of IgG (Ty cells) and 
IgM (TJ.I cells) [8-10]. Early studies of isolated subpopulations 
presented evidence that TJ.L cells were able to provide help to 
polyconal B cell differentiation induced by pokeweed mitogen 
